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genesis, Theiler’s virus has it all. A natural pathogen of
mouse that can be found in feral populations worldwide
and in laboratory colonies kept under poor hygiene con-
ditions, it is the infectious component of a multifactorial
disease that resembles multiple sclerosis (MS). Theiler’s
virus is a picornavirus with a life cycle very similar to that
of poliovirus. It is transmitted by the fecal–oral route and
multiplies in the gut without causing overt symptoms. On
rare occasions it reaches the central nervous system
(CNS) where it may persist in glial cells of the white
matter of spinal cord and cause chronic inflammation
and demyelination. Whereas Max Theiler used his virus
in the 1930’s as a model for poliomyelitis, present day
virologists, following the pioneering work of Daniels,
Pappenheimer Richardson, and then Howard Lipton, are
more interested in the demyelinating disease and its
similarities to MS. Indeed, the infection of the SJL/J
mouse by Theiler’s virus and experimental autoimmune
encephalomyelitis are the most widely used MS models.
The power of the model stems from the fact that the
agent is very well characterized, genetically simple and
amenable to reverse genetics, and that it infects the
mouse, the ideal laboratory animal to study infections
and immune-mediated pathologies. The pathogenesis of
this disease raises two main questions: (i) How does the
agent persist in spite of the immune responses? (ii) What
is the mechanism of demyelination? I will examine some
aspects of both, from a personal viewpoint that may raise
more questions than it will provide answers. Finally, I will
emphasize how preventing and treating human infec-
tious diseases can still benefit enormously from studying
animal models.
GENETIC APPROACHES TO THE PROBLEM
OF PERSISTENCE
Theiler’s virus’s primary habitat is the gut. Interestingly,
virtually nothing is known about the infection at this level.1virus goes from there to the CNS, although there is
evidence that it uses the neural rather than the hema-
togenous route. The reason is that all studies have fo-
cused on the experimental biphasic CNS disease that
follows intracerebral inoculation. The first phase, also
called early disease, is an acute meningoencephalomy-
elitis during which the virus infects neurons. It lasts
approximately 2 weeks. The second phase, or late dis-
ease, is a life-long persistent infection of glial cells of the
white matter of spinal cord accompanied by chronic
inflammation and the destruction of myelin around ax-
ons. It is this late disease which is studied as a model of
MS. There is some discrepancy in the literature regard-
ing the nature of the glial cells that are persistently
infected. However, the consensus is that, at least in SJL/J
mice, the main viral burden is in infiltrating macrophages
and possibly in activated microglial cells (Lipton et al.,
1995; Pena Rossi et al., 1997). However, oligodendro-
cytes, and to some extent astrocytes, are also infected
and may even play a key role in the establishment of
persistence, as will be argued below. Interestingly, neu-
rons are no longer infected during late disease.
Although all mice are susceptible to initial infection
and early disease, some clear the infection after approx-
imately 2 weeks. Others, such as inbred SJL/J mice,
remain infected for life and develop the late, MS-like,
demyelinating disease. Susceptibility/resistance to per-
sistence of the infection and to demyelination is geneti-
cally determined. The existence of inbred mouse strains
with various degrees of susceptibility to persistent infec-
tion—determined by measuring the viral load in CNS—
indicates that the trait is multigenic. Besides the H-2D
class I gene, which has a major effect, several non-H-2
loci responsible for the extreme susceptibility to persis-
tent infection of the SJL/J strain have been mapped and
characterized, including one close to Ifng on chromo-
some 10 (for a review see Brahic and Bureau, 1998).
Viral genetics has helped to study Theiler’s virus’s
pathogenesis because of the existence of two groups ofReceived May 28, 20
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of strains isolated so far, including strains DA and BeAn,
cause the biphasic disease described above. However,
the GDVII and FA strains are exceptions. They spread
very efficiently among neurons, both in vivo and in vitro,
and, as a result, kill most of the animals from acute
encephalomyelitis. Importantly, they do not persist in rare
survivors. Furthermore, attenuated GDVII strains, ob-
tained by introducing mutations in the 5-noncoding re-
gion of the genome, do not kill their hosts and, yet, do not
persist, indicating that specific positive determinants of
persistence are present in the genomes of the DA and
BeAn strains (Jarousse et al., 1999; Lipton et al., 1998).
Using series of recombinants between the two types of
strains and mutant DA or BeAn viruses, several groups
showed that only strains that infect white matter glial
cells persist and that the ability to persist maps predom-
inantly to the viral capsid, in particular to residues lo-
cated around the edge of the “pit,” a depression which is
thought to be the receptor-binding site (see Brahic and
Bureau, 1998 for a review). Unfortunately, the receptor for
Theiler’s virus has not yet been identified. However, we
know that the presence of sialic acid at the surface of
cells is necessary, but not sufficient, for the binding and
entry of persisting strains, whereas it is not necessary in
the case of the GDVII strain (Zhou et al., 2000). Therefore,
the present working hypothesis is that nonpersistent and
persistent strains use different receptors, or use the
same receptor differently, such that the former infects
neurons more efficiently than glial cells and, conversely,
the latter infects glial cells more efficiently than neurons.
Sparing neurons would allow the host to survive and
infecting glial cells would allow the virus to persist. It can
be seen that, according to this hypothesis, cell tropism is
central to the problem of Theiler’s virus persistence.
PERSISTENCE AND THE L* PROTEIN
This viral protein is translated from an alternative read-
ing frame starting 13 nucleotides downstream from the
first AUG codon of the main viral ORF. It may play a role
in persistence because it is expressed by all known
persisting strains of Theiler’s virus but not by the GDVII
and FA strains, and because it facilitates viral replication
in macrophage cell lines (van Eyll and Michiels, 2000).
However, conflicting results have been published re-
garding the persistence of mutant DA viruses which do
not express L*. The discrepancy could be due to minor
variations in the infectious DA clones used by different
groups. Interestingly, the phenotypes of L* mutants was
studied in SJL/J mice, a strain highly susceptible to per-
sistence of the infection and whose macrophages have
unusual properties. It might be interesting to reexamine
this point using less susceptible inbred strains, or sus-
ceptible outbred strains such as the Swiss mouse. In
conclusion, the biological function of L* is still an open
question. The presence of the L* ORF in all persisting
strains argues strongly in favor of some selection pres-
sure to maintain this gene. However, that selection pres-
sure may not be related to persistence in CNS, which is
most likely a dead end as far as virus transmission is
concerned. The role of the L* protein in the biology of
Theiler’s virus may have to be looked for somewhere
else, maybe in the gut.
PERSISTENCE IN MACROPHAGES AND THE ROLE
OF OLIGODENDROCYTES
Although infiltrating macrophages carry the main viral
burden in persistently infected SJL/J mice, oligodendro-
cytes may have a key role in establishing persistence.
This concept stemmed from an unexpected result ob-
tained with mutant mice. The shiverer mutation is a
deletion of a large part of the gene (Mbp) which codes for
the myelin basic protein (MBP). rump shaker, on the
other hand, is a point mutation in the Plp gene, which
codes another myelin structural protein, the proteolipid
protein (PLP). C3H mice homozygous for either mutation
are strikingly resistant to persistent infection, whereas
the parental C3H mice are susceptible. In both cases,
resistance is not immune mediated. Interestingly, C3H
mice heterozygous for the shiverer mutations are more
susceptible to persistent infection than the parental
strain (Bihl et al., 1997). These results tell us that myelin,
or the oligodendrocyte cell body, plays a central role in
allowing the virus to persist. (It has been claimed that the
Mbp and Plp genes are expressed at low levels in mac-
rophages. Because this is controversial, and for the sake
of simplicity, we will ignore it in the rest of the discus-
sion.) The resistance to persistent infection of the mutant
mice is so profound that the step in pathogenesis af-
fected by the mutations must be essential for persis-
tence. What could that step be?
Myelin is an extension of the oligodendrocyte cell
body wrapped many times around the axons. The cyto-
plasm is extruded from these extensions during myeli-
nation, the so-called “compaction” phenomenon. As a
result myelin is a multilamellar structure in which intra-
and extracellular spaces alternate. Some cytoplasm re-
mains in specialized areas of myelin such as the para-
nodal loops and the Schmidt–Lanterman incisures. The
MBP and PLP proteins are two main constituents of
myelin that play important roles in compaction. As a
result, myelin is virtually absent in shiverer mice, and
abnormal in rump shaker animals, although the oligoden-
drocyte cell bodies are maintained in both mutants. One
can therefore hypothesize that the infection of myelin,
which is impossible in the shiverer mouse, is required for
persistence. This is congruent with the fact that Theiler’s
virus antigens have been found in the paranodal loops
and the Schmidt–Lanterman incisures of infected oligo-
dendrocytes (Rodriguez et al., 1983).
Why should myelin infection be required for persis-
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tence? One view, suggested by Howard Lipton, is that
macrophages, the main reservoir during persistence,
become infected by phagocytizing infected myelin. An-
other possibility is that the virus, which uses axonal
transport during early disease, infects the myelin sheath
from the axon. From myelin, the infection could spread to
the oligodendrocyte cell body due to cytoplasm continu-
ity and to other glial cells and macrophages by the
release of extracellular particles. Whatever the mecha-
nism will turn out to be, testing such a model should
uncover new aspects of picornavirus trafficking within
the CNS.
WHY PERSISTENCE IN SPINAL CORD AND NOT
IN BRAIN?
It is striking that Theiler’s virus, although it infects the
gray matter of brain, persists in the white matter of spinal
cord and not in that of brain. This peculiar distribution
must reflect important differences in the biology of glia,
possibly oligodendroglia, in brain and spinal cord. It is
also possible that monocytes acquire different properties
when they infiltrate the brain or the spinal cord and that
they become permissive to viral infection only in the
latter case. All these questions, which could have impli-
cations going far beyond the Theiler’s virus model, re-
main entirely unanswered and would deserve thorough
investigation.
WHY GUT AND CNS?
Theiler’s virus, similar to several other picornaviruses,
infects naive animals by the oral route, lives in the di-
gestive tract for long periods of time without producing
symptoms, and is shed in feces. This lifestyle, which
ensures efficient perpetuation of the agent in the mouse
population, must be the result of a long selection pro-
cess. On the contrary, there is no obvious selection
pressure that would have given the virus the ability to
infect the CNS, whether acutely or persistently, since it is
most likely a dead end for the virus, as far as transmis-
sion is concerned. It is not even a reservoir from which
the virus might infect organs with an access to the
outside, since no virus has been found in any organ
besides CNS during persistent infection, even using
highly sensitive RT-PCR techniques (Trottier et al., 2002).
Interestingly, many other enteric viruses, including sev-
eral enteroviruses, are neurotropic. This may indicate
that cells in the gut share properties, including surface
molecules, that can act as viral receptors, with cells in
the CNS. These cells could be enterocytes or immune
cells in Peyer’s patches, but another possibility, which
has not been much investigated yet, is that enteric vi-
ruses replicate in the abundant neurons and glial cells
which form the enteric nervous system (Gershon et al.,
1993). Adaptation to the CNS, in this case, would have
taken place at the periphery, in the “brain-like” system
present in the wall of the digestive tract to ensure peri-
stalsis.
PERSISTENCE AND AVOIDANCE OF THE INNATE
IMMUNE RESPONSES
The importance of innate immune responses is partic-
ularly well illustrated in the case of Theiler’s virus by the
phenotype of mice with an inactivated gene for the in-
terferon-/ receptor. These mice die of overwhelming
encephalomyelitis a few days following intracranial inoc-
ulation. At the time of death, viral titers in CNS are
extremely high (Fiette et al., 1995). Therefore, in a normal
mouse, the virus replicates under very strong pressure
from the interferon-/ response and one should expect
that it has developed some sort of countermeasure. A
recent article by van Pesch and co-workers demon-
strates that the L protein, a 76 amino acid long protein
corresponding to the N-terminus of the viral polyprotein,
specifically inhibits the transcription of the genes for
interferons alpha-4 and beta, the immediate-early inter-
ferons (van Pesch et al., 2001). This is most likely the
reason the L protein is important for both the neuroviru-
lence of the GDVII strain (Calenoff et al., 1995) and the
persistence of the DA strain (van Pesch et al., 2001).
Understanding the mechanism by which L prevents tran-
scription of the immediate-early interferon genes could
shed new light on the biology of the interferon response.
PERSISTENCE AND AVOIDANCE OF THE SPECIFIC
IMMUNE RESPONSES
The antiinterferon activity of the L protein, although it
contributes to Theiler’s virus pathogenicity, is not enough
to allow the virus to evade all defense mechanisms and
to persist. Indeed, the virus is cleared after the early
disease in mice genetically resistant to persistence of
the infection. A host of data, which I will not review in
detail here, shows that clearance is mediated primarily
by class I restricted CD8 lymphocytes (for a review of
the subject, see Monteyne et al., 1997). In mice suscep-
tible to persistent infection, on the other hand, the bal-
ance between viral activity and host defenses tilts in
favor of the former. Interestingly, the antiviral CTL re-
sponse in the spleen of these mice is slow and weak
compared to that of resistant mice (Dethlefs et al.,
1997a). Therefore, it looks as if the outcome of early
disease depended on a race between viral multiplication
and CTL responses. However, this may be simplistic
since an unpublished observation, quoted in a recent
review, suggests that similar levels of virus-specific
CD8 T lymphocytes are present in the CNS of SJL/J and
C57BL/6 mice (Kim et al., 2001).
Interestingly, virus-specific CTL are H-2K restricted in
SJL/J (Kim et al., 2001) and DBA2 mice (Pena Rossi et al.,
1991), which are susceptible to persistent infection,
whereas they are mostly H-2D restricted in resistant
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C57BL/6 mice (Dethlefs et al., 1997b). In C57BL/6 mice
knock-out for the H-2Db gene, remaining H-2Kb restricted
CTL are unable to clear the virus and the mice remain
persistently infected (Azoulay-Cayla et al., 2000). Why
should H-2Db-, but not H-2Kb-restricted CTL clear the
infection? Although preliminary data indicate that pep-
tide presentation, rather than other properties of the
class I molecule such as pattern of expression, is the
cause (Azoulay-Cayla et al., 2001), we are still a long way
from a complete mechanistic explanation. Important in-
formation is still lacking. For example, most of the exper-
iments on class I restriction of viral clearance have been
performed on splenocytes, for technical reasons, al-
though clearance takes place in CNS. In summary, im-
portant questions on immune evasion by Theiler’s virus
remain entirely open. Solving them might have far-reach-
ing implications for understanding resistance to viral
infections and the for the design of effective vaccines.
DEMYELINATION, ANTIVIRAL IMMUNE
RESPONSES, AND EPITOPE SPREADING
There is now considerable evidence that the demyeli-
nation observed in SJL/J mice persistently infected with
Theiler’s virus is immune mediated, although part of it
could be due to direct virus-induced injury to oligoden-
drocytes. Numerous studies, performed mainly in the
laboratory of Stephen Miller, showed that virus-specific
CD4 T cells with a Th1 phenotype, for which dominant
and subdominant epitopes have been identified, are in-
volved in demyelination (Gerety et al., 1994). On the other
hand, the presence of numerous myelin-laden activated
macrophages in the lesions suggests that macrophages
are effectors of myelin destruction. Based on a large
body of data, Miller and his collaborators proposed the
following scenario: T cells are recruited to the site of
persistent infection and activated by the class II re-
stricted presentation of viral epitopes at the surface of
macrophages/microglial cells that could be infected or
that could have ingested infected cells. Class II re-
stricted presentation and the secretion of IL-12 promotes
a Th1 response. Activated Th1 CD4 T cells produce
proinflammatory chemokines and cytokines which at-
tract and activate more mononuclear inflammatory cells
and resident microglia. In the end, myelin destruction is
due to the chronic secretion of toxic factors, such as
TNF and nitric oxide, by activated inflammatory cells
(innocent bystander mechanism).
Class II restricted presentation of epitopes from the
PLP and MOG myelin proteins, as well as PLP- and
MOG-specific Th1 CD4 T cells, can be demonstrated in
the CNS of SJL/J mice several months after inoculation.
Therefore it appears that, late into disease, autoimmune
demyelination gets superimposed on the innocent by-
stander mechanism described above (Miller and Eagar,
2001). The appearance of autoimmunity as a result of
persistent infection and chronic inflammation is an im-
portant observation. However, the contribution of autore-
active Th1 cells to Theiler’s virus induced demyelination
has not been assessed directly. Miller has argued con-
vincingly that this autoimmune response arises through
“epitope spreading” rather than “molecular mimicry.”
Epitope spreading may require that myelin-loaded mac-
rophages exit the CNS and migrate to lymph nodes
where they could activate autoreactive Th1 cells.
Autoimmunity is clearly not required for Theiler’s virus
induced demyelination since demyelination is already
there before autoreactive T cells can be demonstrated.
Therefore the part played by autoimmunity in Theiler’s
virus induced demyelination is not entirely clear at
present. It would be important to devise a way to elimi-
nate the infection after the onset of autoimmunity to see
if demyelination can continue on a purely autoimmune
mode. The experiment has not been possible yet for the
lack of an efficient antiviral drug. It might be worth ex-
ploring the possibility of genetically engineering a virus
that would persist in CNS for only a limited period of time
or that could be “turned off” at will.
MS is considered an autoimmune disease that results
from particular infections in genetically susceptible indi-
viduals. Therefore the concept of epitope spreading is
very relevant to the pathogenesis of this complex human
disease. The fact that an infectious agent has not been
yet convincingly associated with MS plaques could
mean either that the methods used to look for agents
were inappropriate or that the agent is no longer there by
the time clinical disease has developed.
OF THE IMPORTANCE OF STUDYING
ANIMAL MODELS
There is at present a strong tendency in medicine to
encourage only research that deals with a specific, im-
portant human disease. This is supposedly because per-
fect animal models do not exist, and because new and
more powerful techniques are constantly being devel-
oped and made available for clinical investigations. Al-
though this may be true, clinical investigations, because
one cannot manipulate the system and see how it reacts,
tend to be mainly descriptive and are not conducive to
uncovering new paradigms. Much remains to be learned
about basic aspects of host/pathogen relationship and
new, unexpected concepts will undoubtedly emerge from
well-conceived experimental approaches of infections of
laboratory animals, such as inbred mice. Concepts such
as MHC restriction of immune responses, or the infec-
tivity of prions proteins, came forth from such studies.
More recently, studying the immune responses of insects
has considerably enriched our understanding of innate
immunity in mammals, a field that has been neglected for
a long time. Because life thrives on diversity, one can be
certain that a lot more remains in store which could have
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profound implications for human medicine. Furthermore,
animal models bring big returns for relatively small in-
vestments, compared to clinical research in humans.
Unfortunately, only a handful of laboratories are now
engaged in research on viral diseases of laboratory
animals and they have been the same ones, studying the
same models, for more than a decade. Lets hope that
new generations will soon join in and bring with them
totally new systems with which they will surprise us with
unexpected turns in the virus/host interplay.
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